Wikisage, the free encyclopedia of the second generation, is digital heritage

Topiramate: Difference between revisions

From Wikisage
Jump to navigation Jump to search
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
topiramate compared to [[phenobarbitone|phenobarbital]] result better effect on, both partial, generalized <ref>[http://www.europeanreview.org/wp/wp-content/uploads/993-997.pdf Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital]</ref>
topiramate compared to [[phenobarbitone|phenobarbital]] result better effect on, both partial, generalized <ref>[http://www.europeanreview.org/wp/wp-content/uploads/993-997.pdf Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital]</ref>
Qudexy<sup>TM</sup> is an extended release form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref>
Qudexy<sup>TM</sup> is an [[XR-topiramate|extended release]] form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref>
<gallery>
<gallery>
File:Topiramate_3D.png
File:Under_construction_icon.png
File:Under_construction_icon.png
</gallery>
</gallery>
Line 18: Line 17:


[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307870/pdf/main.pdf Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy]
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307870/pdf/main.pdf Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy]
==ATC==
==[[ATC]]==
 
<gallery>File:Topiramate_3D.png</gallery>
<ref>https://www.whocc.no/atc_ddd_index/?code=N03AX11</ref>
<ref>https://www.whocc.no/atc_ddd_index/?code=N03AX11</ref>
<references/>
 
{{refs}}
 
[[Category:Anticonvulsants]]

Latest revision as of 15:20, 21 May 2019